BOT 1.45% 34.0¢ botanix pharmaceuticals ltd

While still not from BOT so therefore take it with a grain of...

  1. 1,391 Posts.
    lightbulb Created with Sketch. 284
    While still not from BOT so therefore take it with a grain of salt, this is from the E&P report - Page 41

    In the U.S., seven major plans cover approximately 80% of lives, making these engagements crucial. While the progress of these
    negotiations remains somewhat opaque and reliant on optimistic company guidance, it is assumed that Sofdra will be reimbursed at a
    level commensurate with a unit list price of approximately $750 per prescription, with a gross-to-net adjustment of around 30%.
    Last edited by Mikey74: 20/06/24
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
34.0¢
Change
-0.005(1.45%)
Mkt cap ! $615.4M
Open High Low Value Volume
34.0¢ 34.0¢ 32.8¢ $1.949M 5.840M

Buyers (Bids)

No. Vol. Price($)
1 2985 33.5¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 420471 4
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.